Same Schedule, Different Science
Euflexxa and Synvisc share the same 3-injection weekly protocol, making this a pure apples-to-apples comparison of formulation rather than convenience. The schedule is identical. The difference lies entirely in where the HA comes from, how it is processed, and what it means for your specific situation.
This makes the Euflexxa vs. Synvisc decision clearer than most HA comparisons: it comes down to allergy status, source preference, and molecular weight philosophy.
Quick Comparison Table
| Feature | Euflexxa | Synvisc |
|---|---|---|
| Manufacturer | Ferring Pharmaceuticals | Sanofi |
| Source | Bacterial fermentation | Avian (chicken comb) |
| Bird allergy safe | Yes | No |
| Injections needed | 3 weekly | 3 weekly |
| Volume per injection | 2 mL | 2 mL |
| Total volume | 6 mL | 6 mL |
| Molecular weight | 2.4-3.6 million Da | 6 million Da |
| Cross-linked | No | Yes (hylan G-F 20) |
| FDA approval | 2004 | 1997 |
| HCPCS Code | J7323 | J7325 |
| Duration | Up to 6 months | Up to 6 months |
| Self-pay cost | $600-$900 | $700-$1,000 |
What Is Euflexxa?
Euflexxa is a biofermented sodium hyaluronate manufactured by Ferring Pharmaceuticals. It is one of only two non-avian HA products available in the US (the other being Durolane, a single-injection product).
Why Euflexxa Matters
Euflexxa fills a critical gap in the market. Before its approval in 2004, every HA product was derived from rooster combs. For the 2-3% of Americans with egg or poultry allergies, HA injections were simply not an option.
Euflexxa changed that. It proved that bacterially fermented HA could be just as effective as avian-derived products while being safe for allergy-prone patients.
Key Clinical Evidence
The FLEXX trial was the pivotal study that led to Euflexxa’s FDA approval. It demonstrated:
- Statistically significant pain reduction vs. saline placebo at 26 weeks
- Improvement in physical function measured by WOMAC scores
- Good safety profile with side effects similar to placebo
- Non-inferiority to avian-derived comparators
Euflexxa Strengths
What Is Synvisc?
Synvisc (hylan G-F 20) is the original 3-injection version of Sanofi’s cross-linked hyaluronic acid. First approved in 1997, it was the pioneer of viscosupplementation in the United States and remains one of the most well-known brands.
Note: Synvisc is the 3-injection version. Synvisc-One is the single-injection version. This comparison focuses on the 3-injection Synvisc for a direct protocol-to-protocol comparison with Euflexxa.
Key Clinical Evidence
Synvisc has the longest track record of any HA product in the US:
- Nearly 30 years of post-market safety data
- Multiple large randomized controlled trials
- Consistent superiority over saline placebo
- Real-world effectiveness validated across hundreds of thousands of treatments
Synvisc Strengths
The Source Material Difference
Euflexxa: Bacterial Fermentation
- HA produced by Streptococcus bacteria in controlled tanks
- No animal-derived components at any stage
- Highly purified and consistent
- Safe for egg/chicken/feather allergies
- Non-cross-linked (natural HA structure)
Synvisc: Avian Extraction + Cross-Linking
- HA extracted from rooster combs
- Chemically cross-linked to create hylan polymer
- Contains trace avian proteins
- Not safe for egg/chicken/feather allergies
- Cross-linking creates ultra-high MW gel
The Molecular Weight Question
With an identical 3-injection protocol, the molecular weight difference is the most significant formulation distinction:
- Euflexxa: 2.4-3.6 million Da (medium-high, natural)
- Synvisc: 6 million Da (very high, achieved through cross-linking)
Does higher MW mean better results?
Research is mixed. Some in vitro studies suggest higher MW provides better shock absorption. But clinical trials comparing different MW products show similar outcomes for pain relief and function. The theoretical advantage of Synvisc’s ultra-high MW has not been consistently demonstrated as a clinical advantage in real patients.
The Allergy Decision Tree
Do You Have Any of These Allergies?
- Egg allergy
- Chicken or poultry allergy
- Feather allergy
If YES: Choose Euflexxa. Synvisc is contraindicated.
If NO: Both options are safe. Choose based on MW preference, cost, and doctor recommendation.
Cost Comparison
Since both require 3 office visits, the cost difference comes down to drug pricing:
| Factor | Euflexxa | Synvisc |
|---|---|---|
| Drug cost (self-pay) | $600-$900 | $700-$1,000 |
| Office visit copays | 3 x $25-$50 | 3 x $25-$50 |
| Total with Medicare | $125-$250 | $150-$300 |
| Total self-pay | $675-$1,050 | $775-$1,150 |
Euflexxa is typically $100-200 less per treatment series than Synvisc, with similar total costs for both.
Making Your Decision
Choose Euflexxa if:
- You have egg, chicken, or poultry allergies
- You prefer non-animal-derived products
- You want a non-cross-linked formulation
- Lower cost is a factor
- You are concerned about inflammatory reactions from cross-linked products
Choose Synvisc if:
- You have no avian allergies
- You want the highest molecular weight available in a 3-injection product
- You value the longest track record (since 1997)
- Your doctor has extensive Synvisc experience
- You may want to upgrade to Synvisc-One (single injection) later
Frequently Asked Questions
Is Euflexxa as effective as Synvisc?
Yes. Clinical studies show comparable pain relief and functional improvement. The FDA approved Euflexxa based on evidence of safety and efficacy equivalent to established HA products.
Can I switch from Synvisc to Euflexxa?
Yes. The identical 3-injection schedule makes switching seamless. Many patients switch to Euflexxa if they develop avian sensitivities or prefer a non-animal product.
Does Synvisc last longer because of higher molecular weight?
Studies report similar duration (up to 6 months) for both products. The higher MW of Synvisc has not been shown to extend duration of relief clinically.
Which brand does Medicare prefer?
Medicare covers both products equally. There is no preferred brand at the Medicare program level, though specific Medicare Advantage plans may have formulary preferences.
My doctor only stocks one of these. Should I switch doctors?
Not necessarily. Both products are effective, and your doctor’s experience and skill matter more than which specific brand they use. If you have avian allergies, however, make sure your provider offers a non-avian option like Euflexxa or Durolane.
The Bottom Line
Same Schedule, Different Source
Euflexxa and Synvisc are both effective 3-injection HA treatments with similar clinical outcomes. The choice is simpler than most HA comparisons:
- Have avian allergies? Euflexxa is your only option.
- Want the highest MW? Synvisc has it at 6 million Da.
- Want lower cost? Euflexxa is typically $100-200 cheaper.
- Want longest track record? Synvisc has nearly 30 years.
- No strong preference? Either works well. Trust your doctor’s recommendation.
Find HA Injection Providers
Connect with specialists offering Euflexxa, Synvisc, and other viscosupplementation products.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderRelated Comparisons
HA Treatment Updates
Stay informed about viscosupplementation options for knee osteoarthritis.
Join 10,000+ readers. No spam.